In a huge off-the-field win for Tom Brady and the New England Patriots, Judge Richard Berman of Federal District Court in Manhattan overturned the star quarterback's four game suspension on Thursday. But, founder & president of U/S Sports Advisors Ken Ungar says the National Football League will not back down and the fight will continue. Brady has been in a court battle with the NFL and league commissioner Roger Goodell for allegedly being involved in a scandal dubbed 'Deflategate.' The controversy stems from accusations that the Patriots football team deflated the footballs used in the AFC championship game back in January. Ungar says there are huge issues at stake for the NFL, which is why it decided so quickly to appeal this ruling. Additionally, there is a lot at risk for the player's association, because they want to make sure the commissioner acts in accordance with the bargaining agreement. In a 40-page document outlining the decision, the judge lays out the reasons for vacating the suspension issued by the NFL. The papers point to inadequate notice to Tom Brady of the alleged misconduct and discipline, denial of the opportunity to question one of the two lead investigators, as well as the denial of equal access to files. Regardless of the ultimate outcome, Ungar sees a big negative impact on Brady's earnings power as a result of this scandal.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.